EUDA Health Holdings Limited (EUDA)vsJones Lang LaSalle Incorporated (JLL)
EUDA
EUDA Health Holdings Limited
$11.47
+25.63%
REAL ESTATE · Cap: $692,070
JLL
Jones Lang LaSalle Incorporated
$300.19
+1.33%
REAL ESTATE · Cap: $13.98B
Smart Verdict
WallStSmart Research — data-driven comparison
Jones Lang LaSalle Incorporated generates 505987% more annual revenue ($26.12B vs $5.16M). EUDA leads profitability with a 5.2% profit margin vs 3.0%. EUDA trades at a lower P/E of 0.9x. JLL earns a higher WallStSmart Score of 72/100 (B).
EUDA
Hold36
out of 100
Grade: F
JLL
Strong Buy72
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.0%
Fair Value
$2.72
Current Price
$11.47
$8.75 discount
Margin of Safety
+60.5%
Fair Value
$767.99
Current Price
$300.19
$467.80 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Revenue surging 60.2% year-over-year
Conservative balance sheet, low leverage
Earnings expanding 68.1% YoY
Growing faster than its price suggests
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
5.2% margin — thin
3.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : EUDA
The strongest argument for EUDA centers on P/E Ratio, Revenue Growth, Debt/Equity. Revenue growth of 60.2% demonstrates continued momentum.
Bull Case : JLL
The strongest argument for JLL centers on EPS Growth, PEG Ratio, Price/Book. Revenue growth of 11.7% demonstrates continued momentum. PEG of 0.99 suggests the stock is reasonably priced for its growth.
Bear Case : EUDA
The primary concerns for EUDA are EPS Growth, Market Cap, Return on Equity.
Bear Case : JLL
The primary concerns for JLL are Profit Margin. Thin 3.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
EUDA profiles as a hypergrowth stock while JLL is a value play — different risk/reward profiles.
JLL carries more volatility with a beta of 1.44 — expect wider price swings.
EUDA is growing revenue faster at 60.2% — sustainability is the question.
JLL generates stronger free cash flow (928M), providing more financial flexibility.
Bottom Line
JLL scores higher overall (72/100 vs 36/100) and 11.7% revenue growth. EUDA offers better value entry with a 68.0% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
EUDA Health Holdings Limited
REAL ESTATE · REAL ESTATE SERVICES · USA
EUDA Health Holdings Limited is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative therapies for rare diseases and unmet medical needs. Utilizing advanced technologies and a dynamic pipeline, the company aims to tackle critical challenges in supportive care and immune modulation. With a strong emphasis on research and development, EUDA is well-positioned to lead healthcare innovation, committed to improving patient outcomes and expanding access to vital medical therapies through its promising clinical programs.
Visit Website →Jones Lang LaSalle Incorporated
REAL ESTATE · REAL ESTATE SERVICES · USA
Jones Lang LaSalle Incorporated, a professional services company, provides real estate and investment management services in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Chicago, Illinois.
Compare with Other REAL ESTATE SERVICES Stocks
Want to dig deeper into these stocks?